Long-Acting Bronchodilators And Risk of Adverse Cardiovascular Events In Chronic Obstructive Pulmonary Disease: A Focused Critical Review

Value in Health ◽

10.1016/j.jval.2015.03.980 ◽

2015 ◽

Vol 18 (3) ◽

pp. A169

Author(s):

S. Tao ◽

E. Kirsch ◽

K. Yeomans ◽

C. Sigler

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Critical Review ◽

Cardiovascular Events ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease

Journal of Food and Drug Analysis ◽

10.1016/j.jfda.2018.12.006 ◽

2019 ◽

Vol 27 (3) ◽

pp. 657-670 ◽

Author(s):

Meng-Ting Wang ◽

Jyun-Heng Lai ◽

Chen-Liang Tsai ◽

Jun-Ting Liou

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Cardiovascular Events ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Download Full-text

CHRONIC KIDNEY DISEASE LEADS TO ADVERSE CARDIOVASCULAR EVENTS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS USING INHALED LONG-ACTING BRONCHODILATORS

Respirology ◽

10.1111/resp.13420_90 ◽

2018 ◽

Vol 23 ◽

pp. 122-123

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Pulmonary Disease ◽

Cardiovascular Events ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Download Full-text

THE RISK OF CARDIOVASCULAR EVENTS ASSOCIATED WITH INHALED LONG-ACTING BETA-2-ADRENORECEPTOR AGONISTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEST Journal ◽

10.1378/chest.130.4_meetingabstracts.121s-d ◽

2006 ◽

Vol 130 (4) ◽

pp. 121S ◽

Author(s):

Sarika S. Ogale ◽

Todd A. Lee ◽

Sean D. Sullivan

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Cardiovascular Events ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Beta 2 ◽

Download Full-text

Faculty of 1000 evaluation for Long-acting beta2-agonists for chronic obstructive pulmonary disease.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718144330.793486777 ◽

2013 ◽

Author(s):

Mark Dransfield ◽

Michael Wells ◽

Surya Bhatt

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Faculty Opinions recommendation of Combined corticosteroid and long-acting beta₂-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718170810.793489148 ◽

2014 ◽

Author(s):

Alice Turner ◽

Stan Ejiofor

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Beta Agonist ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Combination Therapy of Inhaled Corticosteroids and Long-Acting β2- Adrenergics In Management of Patients with Chronic Obstructive Pulmonary Disease

Current Pharmaceutical Design ◽

10.2174/1381612043382990 ◽

2004 ◽

Vol 10 (28) ◽

pp. 3547-3560 ◽

Author(s):

Don Sin ◽

Malcolm Johnson ◽

Wen Gan ◽

S. F. Man

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Combination Therapy ◽

Pulmonary Disease ◽

Inhaled Corticosteroids ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Download Full-text

A Systematic and Critical Review of Discrete Choice Experiments in Asthma and Chronic Obstructive Pulmonary Disease

The Patient: Patient-Centered Outcomes Research ◽

10.1007/s40271-021-00536-w ◽

2021 ◽

Author(s):

Hannah Collacott ◽

Dian Zhang ◽

Sebastian Heidenreich ◽

Tommi Tervonen

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Discrete Choice ◽

Critical Review ◽

Choice Experiments ◽

Discrete Choice Experiments ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease

Download Full-text

Review: Inhaled anticholinergics increase risk for major cardiovascular events in chronic obstructive pulmonary disease

Annals of Internal Medicine ◽

10.7326/0003-4819-150-2-200901200-02006 ◽

2009 ◽

Vol 150 (2) ◽

pp. JC1 ◽

Author(s):

Matthew B. Stanbrook

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Cardiovascular Events ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Major Cardiovascular Events ◽

Download Full-text

Characteristics of Patients with Chronic Obstructive Pulmonary Disease (COPD) Receiving Inhaled Corticosteroid/Long-Acting b2-ß2-agonist (ICS/LABA) Fixed Combination Products in English Primary Care

Value in Health ◽

10.1016/j.jval.2013.08.252 ◽

2013 ◽

Vol 16 (7) ◽

pp. A366

Author(s):

B.T. Blak ◽

U. Rigney ◽

C. Emmas ◽

A. Hamblin

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Primary Care ◽

Pulmonary Disease ◽

Fixed Combination ◽

Chronic Obstructive ◽

Inhaled Corticosteroid ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study

Internal and Emergency Medicine ◽

10.1007/s11739-018-1922-y ◽

2018 ◽

Vol 13 (8) ◽

pp. 1349-1349 ◽

Author(s):

Valeria Raparelli ◽

◽

Daniele Pastori ◽

Serena Francesca Pignataro ◽

Anna Rita Vestri ◽

...

Keyword(s):

Atrial Fibrillation ◽

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Cardiovascular Events ◽

Major Adverse Cardiovascular Events ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease

Download Full-text